THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 93 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q3 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $125,000 | +66.7% | 197,207 | +25.6% | 0.00% | – |
| Q4 2015 | $75,000 | -95.0% | 157,001 | -57.0% | 0.00% | -100.0% |
| Q3 2015 | $1,488,000 | -5.3% | 365,498 | -6.0% | 0.00% | 0.0% |
| Q2 2015 | $1,572,000 | +5.9% | 388,905 | +6.3% | 0.00% | +100.0% |
| Q1 2015 | $1,485,000 | +5.0% | 365,882 | -17.7% | 0.00% | 0.0% |
| Q4 2014 | $1,414,000 | -5.2% | 444,474 | +7.6% | 0.00% | 0.0% |
| Q3 2014 | $1,491,000 | +50.3% | 413,043 | +64.9% | 0.00% | 0.0% |
| Q2 2014 | $992,000 | -21.3% | 250,494 | -5.4% | 0.00% | 0.0% |
| Q1 2014 | $1,260,000 | +21.5% | 264,808 | +19.2% | 0.00% | 0.0% |
| Q4 2013 | $1,037,000 | +19.5% | 222,109 | +19.0% | 0.00% | 0.0% |
| Q3 2013 | $868,000 | -28.2% | 186,648 | -18.8% | 0.00% | 0.0% |
| Q2 2013 | $1,209,000 | +59.1% | 229,743 | +39.3% | 0.00% | 0.0% |
| Q1 2013 | $760,000 | – | 164,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 555,965 | $2,007,000 | 2.02% |
| FORTALEZA ASSET MANAGEMENT INC/ | 96,925 | $350,000 | 0.16% |
| Rhenman & Partners Asset Management AB | 121,537 | $439,000 | 0.13% |
| Baker Brothers Advisors | 2,158,141 | $7,791,000 | 0.10% |
| Perceptive Advisors | 160,000 | $578,000 | 0.06% |
| FEDERATED HERMES, INC. | 4,391,838 | $15,855,000 | 0.05% |
| Spark Investment Management LLC | 61,100 | $219,000 | 0.03% |
| SMITH ASSET MANAGEMENT GROUP LP | 190,378 | $687,000 | 0.02% |
| Princeton Alpha Management LP | 28,329 | $102,000 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 31,000 | $112,000 | 0.02% |